List of works by Daniela Pugliese

Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis.

scientific article published on 27 May 2013

Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care

scientific article published on 18 October 2020

Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.

scientific article published on 30 September 2016

Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?

scientific article

Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience

scientific article published on 19 May 2011

Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign

scientific article published on 21 October 2019

Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitis

scientific article

Difference in treatment outcomes between clinical trials and "real-life" clinical practice: ustekinumab in ulcerative colitis

scientific article published on 01 February 2020

Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study".

scientific article published on 21 September 2016

Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease

scientific article published on 03 September 2019

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.

scientific article

FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents

scientific article published on 26 August 2013

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

article

Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.

scientific article published on 13 October 2016

Frontiers in Drug Research and Development for Inflammatory Bowel Disease

scientific article

IBD: Adalimumab for ulcerative colitis— is the glass half empty or half full?

scientific article published on 01 May 2011

Ileal Crohn's disease: CEUS determination of activity.

scientific article published on June 2012

Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.

scientific article

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

scientific article published on 21 May 2020

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.

scientific article published on 20 February 2018

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis

scientific article published in August 2014

Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study

scientific article published on 01 December 2020

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab

scientific article published on 08 April 2013

Management of perianal fistulas in Crohn's disease: an up-to-date review

scientific article published on February 2015

Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.

scientific article published on 7 March 2018

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.

scientific article published on 9 April 2018

Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study.

scientific article published on 31 July 2015

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.

scientific article published on 30 March 2012

Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study

scientific article published on 13 April 2019

Real-word incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors

scientific article published on 20 October 2019

Reply to managing patients with ulcerative colitis with infliximab in primary and referral gastroenterology centers

scientific article published on 01 December 2014

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study

scientific article published on 03 October 2018

Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients

scientific article published on 19 October 2020

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

scientific article published on 12 January 2017

The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases

scientific article published on 11 January 2019

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study

scientific article published on 01 August 2018

Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases

scientific article published on 07 May 2015

Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study

scientific article published on 17 November 2020

Update on the management of inflammatory bowel disease: specific role of adalimumab.

scientific article

What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

scientific article

Paulina is supported by:

About Paulina

Help